Super-resolution microscopy in combination with genetic labeling methods allows imaging of single proteins in cells. However, visualizing endogenous proteins on primary cells remains challenging due to the use of sterically demanding antibodies for labeling. Here, we demonstrate how immunolabeling conditions and antibody cross-linking influence the quantification and identification of membrane receptor stoichiometry on cells using single-molecule localization microscopy. We developed an optimized immunolabeling and analysis protocol and demonstrate the performance of the approach by resolving the molecular organization of endogenous CD45, CD69, and CD38 on Jurkat T cells. To demonstrate the usefulness of the method for immunotherapy applications, we investigated the interaction of primary multiple myeloma cells with the therapeutic monoclonal antibodies daratumumab and isatuximab and a polyclonal anti-CD38 antibody. Our approach might lay the foundation for improved personalized diagnostics and treatment with therapeutic antibodies.
Transsynaptic nanocolumns are nanoscale alignments of pre- and postsynaptic proteins that ensure efficient synaptic transmission. Autoantibodies against the transsynaptic protein LGI1, implicated in LGI1 autoimmune encephalitis, are known to disrupt synaptic function, but their impact on nanocolumn architecture remains unclear. To investigate this, we employed a multi-modal super-resolution imaging strategy combining post-gelation immunolabeling, expansion microscopy with Airyscan super-resolution imaging and compared the results with another advanced super-resolution microscopy technique – d STORM. By physically expanding hippocampal neuron cultures 10.3-fold, our approach enabled decrowding of dense synaptic regions and improved epitope accessibility as well as labeling efficiency. Post-expansion immunolabeling followed by multicolor Airyscan imaging achieved 20–30 nm resolution, allowing detailed visualization of transsynaptic nanocolumns. With this approach we observed LGI1 autoantibody-induced sharpening of Munc13-1 – GluA1 alignment and a shift in AMPA receptor positioning. These findings highlight how advanced expansion-based imaging enables quantitative analysis of nanoscale synaptic alterations in disease contexts.
24 August 2026 in Angewandte Chemie International Edition
Understanding the complex interplay between therapeutic monoclonal antibodies (mAbs) and target receptors within the plasma membrane is essential for improving immunotherapy efficacy. However, direct visualization of lipid nanodomains remains challenging due to their nanoscale dimensions and dynamic behavior. Here, we combine expansion microscopy (ExM) with a fluorescent perfringolysin O domain‐4 probe to map cholesterol‐rich nanodomains in the membrane of whole intact cells with a spatial resolution approaching ∼40 nm on a confocal setup. We demonstrate that cholesterol‐rich domains predominantly localize to actin‐supported membrane protrusions in COS‐7 cells. We directly visualize how the binding of therapeutic mAbs rituximab (RTX) and daratumumab (DARA) redistributes CD20 and CD38 on lymphoma and multiple myeloma cells, respectively, into cholesterol‐rich nanodomains. Accumulation of receptor/mAb complexes within lipid nanodomains creates Fc fragment‐dense regions that enhance signal transduction, apoptotic signaling, and complement‐dependent cytotoxicity. Furthermore, RTX binding induces pronounced B‐cell polarization and accumulation of CD20/RTX complexes in cholesterol‐rich membrane nanodomains, whereas CD38/DARA complexes exhibit a more homogeneous membrane distribution indicating that mAb binding‐induced receptor reorganization occurs in a cell‐type‐ and receptor‐dependent manner at the nanoscale. Our results show how ExM can be used advantageously to improve our understanding of the complex interplay of mAbs and lipid nanodomains.
Understanding the complex interplay between therapeutic monoclonal antibodies (mAbs) and target receptors within the plasma membrane is essential for improving immunotherapy efficacy. However, direct visualization of lipid nanodomains remains challenging due to their nanoscale dimensions and dynamic behavior. Here, we combine expansion microscopy (ExM) with a fluorescent perfringolysin O domain‐4 probe to map cholesterol‐rich nanodomains in the membrane of whole intact cells with a spatial resolution approaching ∼40 nm on a confocal setup. We demonstrate that cholesterol‐rich domains predominantly localize to actin‐supported membrane protrusions in COS‐7 cells. We directly visualize how the binding of therapeutic mAbs rituximab (RTX) and daratumumab (DARA) redistributes CD20 and CD38 on lymphoma and multiple myeloma cells, respectively, into cholesterol‐rich nanodomains. Accumulation of receptor/mAb complexes within lipid nanodomains creates Fc fragment‐dense regions that enhance signal transduction, apoptotic signaling, and complement‐dependent cytotoxicity. Furthermore, RTX binding induces pronounced B‐cell polarization and accumulation of CD20/RTX complexes in cholesterol‐rich membrane nanodomains, whereas CD38/DARA complexes exhibit a more homogeneous membrane distribution indicating that mAb binding‐induced receptor reorganization occurs in a cell‐type‐ and receptor‐dependent manner at the nanoscale. Our results show how ExM can be used advantageously to improve our understanding of the complex interplay of mAbs and lipid nanodomains.